Eisenmenger syndrome

Pathophysiology and Definition

Eisenmenger syndrome represents the extreme end of the spectrum of pulmonary arterial hypertension associated with congenital heart disease.
It occurs when an uncorrected congenital cardiac defect with an initial left-to-right shunt (such as a ventricular septal defect, atrial septal defect, or patent ductus arteriosus) exposes the pulmonary vasculature to chronic high blood flow and/or high pressure.
This chronic exposure leads to progressive, irreversible pulmonary vascular obstructive disease, which is characterized histologically by medial hypertrophy, intimal proliferation, and eventually plexiform lesions.
As pulmonary vascular resistance rises to reach near-systemic or supra-systemic levels, the initial left-to-right shunt reverses and becomes bidirectional or totally right-to-left.
The right-to-left shunting introduces deoxygenated blood directly into the systemic circulation, resulting in chronic central cyanosis and severe systemic hypoxemia.

Patients characteristically present with exertional dyspnea, extreme fatigue, palpitations, syncope, and peripheral edema.
Central cyanosis and marked digital clubbing are hallmark physical findings of the prolonged hypoxemia.
In patients where the underlying defect is a patent ductus arteriosus, "differential cyanosis" classically occurs; the lower body and lower extremities are cyanotic with clubbed toes, while the upper body (such as the right arm) receives oxygenated blood and remains pink.
Chronic cyanosis leads to multiple severe systemic complications, including secondary erythrocytosis, iron deficiency, hyperviscosity syndrome, renal dysfunction, cholelithiasis, and gout.
Patients have a significant bleeding diathesis and are at elevated risk for hemoptysis, while simultaneously facing thrombotic risks such as cerebrovascular accidents (stroke), paradoxical emboli, and brain abscesses.

The typical loud systolic murmur associated with the original left-to-right shunt (such as a VSD murmur) often disappears because the pressures between the ventricles or great arteries equalize, abolishing high-velocity flow.
The second heart sound (S2) is usually single or narrowly split with a loud, booming, and frequently palpable pulmonary component (P2) reflecting the severe pulmonary hypertension.
A high-pitched, early diastolic decrescendo murmur of pulmonary regurgitation (Graham-Steell murmur) is frequently audible along the left sternal border.
A holosystolic murmur of tricuspid regurgitation may be heard at the lower left sternal border as the right ventricle dilates.
Right-sided third (S3) or fourth (S4) heart sounds may be present, particularly in decompensated right heart failure.

The ECG consistently demonstrates severe right ventricular hypertrophy (RVH), often presenting with an upright T wave and increased R wave voltage in lead V1.
The QRS axis is typically deviated to the right.
Signs of right atrial or biatrial enlargement, manifesting as tall, spiked P waves (P pulmonale), are frequently present.

Characteristically reveals massive prominence and dilation of the main pulmonary artery as well as the proximal right and left pulmonary arteries.
In contrast to the enlarged central vessels, the peripheral lung fields appear oligemic, demonstrating a sudden tapering of vessel caliber known as "peripheral pruning".
The overall heart size can vary from normal to greatly enlarged, with cardiomegaly becoming more prominent in the advanced stages of the disease when right heart failure supervenes.

Echocardiography confirms the underlying congenital cardiac defect, demonstrates a thick-walled, hypertrophied right ventricle, and visualizes the bidirectional or right-to-left shunting.
Continuous and color Doppler interrogation of tricuspid and pulmonary regurgitation jets allows for the estimation of the significantly elevated pulmonary artery systolic and diastolic pressures.

Patients must strictly avoid dehydration, extreme physical exertion, high altitudes, and exposure to excessive heat.
Pregnancy carries an extremely high maternal mortality risk (up to 50%) and is strongly contraindicated. Intravenous or subdermal contraception is preferred over estrogen-containing pills to minimize thromboembolic risks.

Routine phlebotomy (venesection) is highly discouraged as it induces iron deficiency, which diminishes the oxygen-carrying capacity of red blood cells and worsens outcomes.
Phlebotomy is strictly reserved for patients with severe hyperviscosity symptoms associated with excessive hematocrit levels, provided dehydration is ruled out, and must be accompanied by simultaneous isovolumetric fluid replacement.
Iron supplementation is indicated to treat iron deficiency, improving symptoms of chronic cyanosis and secondary erythrocytosis.

Advanced pulmonary vasodilator therapies have been shown to significantly improve functional capacity and hemodynamics in Eisenmenger patients.
Options include endothelin receptor antagonists (e.g., Bosentan), phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil), and prostanoids (e.g., epoprostenol, treprostinil). Combination therapy may be required if the disease progresses.
Diuretics are utilized cautiously to optimize right ventricular preload and manage right-sided heart failure symptoms like peripheral edema and ascites.
Routine systemic anticoagulation is generally avoided due to the high risk of fatal hemoptysis and bleeding, unless specific indications like atrial fibrillation or in situ pulmonary artery thrombosis are present.

Corrective surgery of the underlying cardiac defect is strictly contraindicated once irreversible Eisenmenger physiology is established.
For patients who continue to deteriorate symptomatically despite maximal targeted medical therapy, combined heart-lung transplantation or bilateral lung transplantation with concurrent cardiac repair remains the only definitive surgical option.